Vertex Pharmaceuticals
(NASDAQ:VRTX)
$422.78
3.79[0.90%]
At close: May 10
$422.78
0[0.00%]
After Hours: 4:00PM EDT
Q1 2024 Earnings were released on Mon May 6th, after the market close
The most recent conference call was at 16:30 PM, 5 days ago Click to view past webcast
OverviewNewsEarningsGuidanceDividendsAnalyst RatingsInsider TradesShort Interest
62.5%
Overview Rating
Good
Technicals Analysis
100
0100
Financials Analysis
40
0100

Vertex Pharmaceuticals Stock (NASDAQ:VRTX), Quotes and News Summary

Vertex Pharmaceuticals Stock (NASDAQ: VRTX) stock price, news, charts, stock research, profile.

Open$420.670
Close$422.780
Volume / Avg.1.065M / 1.044M
Day Range417.500 - 423.320
52 Wk Range320.010 - 448.400
Market Cap$109.100B
P/E Ratio27.189
Dividend Yield-
ExchangeNASDAQ
RSI
69
Short Interest
1.56%
Days to Cover4.39

Recent News

US Stocks Eye Fourth Positive Session Despite Hawkish Fed Remarks; Disney, Palantir Tumble; Treasury Yields Fall: What's Driving Markets Tuesday?
Wall Street experienced a quiet session during morning trading on Tuesday, influenced by a lack of significant economic data and minimal updates on earnings from major large-cap companies.
Piero Cingari
$100B Vertex Pharma Working To Recreate $10B Cystic Fibrosis Success - This Time Focused On Pain Management Drugs
Unlock Vertex Pharmaceuticals' pioneering treatments, from the groundbreaking Trikafta for cystic fibrosis to the promising non-opioid painkillers.
Vandana Singh
Tesla To $123? Here Are 10 Top Analyst Forecasts For Thursday
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.
Avi Kapoor
40%

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change
Analyst Trend
5
1
Jan
8
1
Feb
5
1
Apr
2
May
Buy
Hold
Sell
Strong Sell
Analyst Rating
12345
3.6
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Compare

EPS better than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
VRTX
LEGN

FAQ

Q

How do I buy Vertex Pharmaceuticals (VRTX) stock?

A

You can purchase shares of Vertex Pharmaceuticals (NASDAQ: VRTX) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Vertex Pharmaceuticals's (VRTX) competitors?

A

Other companies in Vertex Pharmaceuticals’s space includes: Legend Biotech (NASDAQ:LEGN), Sarepta Therapeutics (NASDAQ:SRPT), Exact Sciences (NASDAQ:EXAS), Neurocrine Biosciences (NASDAQ:NBIX) and Cerevel Therapeutics Hldg (NASDAQ:CERE).

Q

What is the target price for Vertex Pharmaceuticals (VRTX) stock?

A

The latest price target for Vertex Pharmaceuticals (NASDAQ: VRTX) was reported by RBC Capital on Tuesday, May 7, 2024. The analyst firm set a price target for 424.00 expecting VRTX to rise to within 12 months (a possible 0.29% upside). 72 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Vertex Pharmaceuticals (VRTX)?

A

The stock price for Vertex Pharmaceuticals (NASDAQ: VRTX) is $422.78 last updated May 10, 2024 at 4:00 PM EDT.

Q

Does Vertex Pharmaceuticals (VRTX) pay a dividend?

A

There are no upcoming dividends for Vertex Pharmaceuticals.

Q

When is Vertex Pharmaceuticals (NASDAQ:VRTX) reporting earnings?

A

Vertex Pharmaceuticals’s Q2 earnings are confirmed for Tuesday, July 30, 2024.

Q

Is Vertex Pharmaceuticals (VRTX) going to split?

A

There is no upcoming split for Vertex Pharmaceuticals.

Q

What sector and industry does Vertex Pharmaceuticals (VRTX) operate in?

A

Vertex Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

People Also Watch